Sep 2026 (Q3 FY26) — Oct 21, 2026
Bridgewater Bancshares Q3 FY26 — Record Revenue and NIM Expansion
Read the full callBridgewater Bancshares earnings: last reported Wed, 21 Oct 2026, for the quarter ended Sep 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 14.0 | +21.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
1 of 1 judged target kept · 4 open · verdicts reflect calls analysed to Sep 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Noninterest expense | relatively stable with second quarter levels | Jun 2026 | However, we outperformed this as expenses came in even lower. | Achieved |
| Loan growth | mid- to high single-digit pace | Jun 2026 | Overall, we expect near-term loan growth in the mid-single-digit range as we navigate this higher rate environment and continue to emphasize profitable growth. | Revised Down |
| Net Interest Margin | hold relatively stable at current levels | Sep 2026 | We expect the net interest margin to hold relatively stable at current levels over the near term, even assuming an additional rate hike in December and two more in early 2027. | New |
4 of Bridgewater Bancshares Inc's 5 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 2 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $16.9 on 22 Oct 2025 → $20.58. High $22.49 (16 Jul 2026), low $16.17 (18 Nov 2025).
Overview
Guidance
1 of 1 judged target kept · 4 open · verdicts reflect calls analysed to Sep 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Noninterest expense | relatively stable with second quarter levels | Jun 2026 | However, we outperformed this as expenses came in even lower. | Achieved |
| Loan growth | mid- to high single-digit pace | Jun 2026 | Overall, we expect near-term loan growth in the mid-single-digit range as we navigate this higher rate environment and continue to emphasize profitable growth. | Revised Down |
| Net Interest Margin | hold relatively stable at current levels | Sep 2026 | We expect the net interest margin to hold relatively stable at current levels over the near term, even assuming an additional rate hike in December and two more in early 2027. | New |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 5 tracked commitments, with each call’s wording and source.
Call summaries
Bridgewater Bancshares Q3 FY26 — Record Revenue and NIM Expansion
Read the full callBridgewater Bancshares Q2 FY26 — Strong Profitability and Strategic Growth
Read the full callEvery analysed call
Financials
Net profit, year on year: +22% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Profit before tax | 11 | 11 | 13 | 15 | 15 | 17 | 23 | 18 |
| Tax rate | 23.6% | 22.0% | 23.9% | 23.9% | 23.1% | 22.2% | 23.8% | 24.1% |
| Net profit | 9 | 8 | 10 | 12 | 12 | 13 | 17 | 14 |
| EPS ($ per share) | 0.28 | — | 0.31 | 0.38 | 0.38 | — | 0.59 | 0.47 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 96 | 128 | 155 | 199 | 249 | 281 | 309 | 351 |
| Total liabilities | 1,753 | 2,024 | 2,662 | 3,098 | 3,952 | 4,186 | 4,608 | 4,890 |
| Fixed assets | 13 | 28 | 51 | 49 | 48 | 49 | 50 | 52 |
| Total assets | 1,974 | 2,269 | 2,927 | 3,478 | 4,346 | 4,612 | 5,066 | 5,407 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 29 | 40 | 23 | 54 | 85 | 30 | 46 | 28 |
| Cash from investing | -354 | -276 | -530 | -571 | -938 | -209 | -95 | -417 |
| Cash from financing | 330 | 240 | 636 | 500 | 797 | 221 | 150 | 283 |
| Net cash flow | 5 | 3 | 129 | -17 | -56 | 42 | 101 | -106 |
| Capital expenditure | -4 | -16 | -25 | -1 | -2 | -3 | -4 | -6 |
| Free cash flow | 26 | 24 | -2 | 53 | 83 | 27 | 42 | 22 |
| KPI | Jun 2026 Q2 FY26 | Sep 2026 Q3 FY26 | Change vs prior quarter |
|---|---|---|---|
| Net interest margin | 3.07%We reported a second quarter margin of 3.07%, which exceeds the 3% goal we set at the end of 2026.Source: earnings call transcript | 3.09%As expected, the pace of net interest margin expansion slowed from the second quarter, but was still up 2 basis points to 3.09% as the loan portfolio continued to reprice higher, while deposit costs remained relatively stable.Source: earnings call transcript | 0 pt |
| Common equity tier 1 ratio (CET1) | 9.61%We continue to build capital through retained earnings during the second quarter as our CET1 ratio increased 8 basis points to 9.61% and is now 58 basis points year-over-year.Source: earnings call transcript | 9.63%Notably, our CET1 ratio has increased 55 basis points year-over-year to 9.63%.Source: earnings call transcript | 0 pt |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
131 filings between Oct 27, 2025 and Sep 30, 2026.
Purchases
$239.3K
2 purchases by 2 insiders
Sales
$10.82M
43 sales by 11 insiders
Also filed: 5 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Shellberg Jeffrey D. | — | $5.53M | Aug 6, 2026 |
| Baack Jerry J. | — | $2.68M | Aug 17, 2026 |
| Juran David B. | — | $912.1K | Sep 2, 2026 |
| Crocker Mary Jayne | $4.1K | $677.3K | Aug 4, 2026 |
| Chybowski Joseph M. | — | $348.7K | Jun 5, 2026 |
| Trutna Thomas P. | — | $253.7K | Feb 10, 2026 |
| Volk David J. | $235.2K | — | Oct 27, 2025 |
| Place Nicholas L. | — | $115.2K | Jun 5, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Juran David B. Director | Award | 969 | $0 |
| Sep 30, 2026 | Johnson James S. Director | Award | 969 | $0 |
| Sep 30, 2026 | Urness Todd B. Director | Award | 969 | $0 |
| Sep 30, 2026 | Parish Douglas J. Director | Award | 484 | $0 |
| Sep 30, 2026 | Crocker Mary Jayne Director | Award | 484 | $0 |
| Sep 30, 2026 | Trutna Thomas P. Director | Award | 484 | $0 |
| Sep 30, 2026 | Volk David J. Director | Award | 969 | $0 |
| Sep 30, 2026 | Brezonik Lisa Director | Award | 969 | $0 |
| Sep 30, 2026 | Lawal Mohammed Director | Award | 969 | $0 |
| Sep 15, 2026 | Stejskal Jessica Anne Chief Experience Officer | Sale | 400 | $8.5K |
| Sep 9, 2026 | Parish Douglas J. Director | Sale | 4,000 | $85.5K |
| Sep 2, 2026 | Juran David B. Director | Sale | 623 | $13.4K |
| Aug 31, 2026 | Shellberg Jeffrey D. Director | Option exercise | 6,250 | $80.8K |
| Aug 31, 2026 | Shellberg Jeffrey D. Director | Option exercise | 16,100 | $281.8K |
| Aug 31, 2026 | Shellberg Jeffrey D. Director | Tax withheld | 17,206 | $362.5K |
| Aug 28, 2026 | Juran David B. Director | Sale | 518 | $11.1K |
| Aug 25, 2026 | Juran David B. Director | Sale | 940 | $20.2K |
| Aug 24, 2026 | Juran David B. Director | Sale | 25,000 | $543.4K |
| Aug 21, 2026 | Juran David B. Director | Sale | 15,000 | $323.9K |
| Aug 17, 2026 | Baack Jerry J. CEO | Sale | 10,000 | $224.8K |
| Aug 14, 2026 | Baack Jerry J. CEO | Sale | 15,000 | $333.2K |
| Aug 13, 2026 | Baack Jerry J. CEO | Sale | 10,000 | $220.3K |
| Aug 6, 2026 | Shellberg Jeffrey D. Director | Sale | 40,000 | $850.3K |
| Aug 5, 2026 | Shellberg Jeffrey D. Director | Sale | 160,000 | $3.37M |
| Aug 4, 2026 | Crocker Mary Jayne Director | Sale | 11,000 | $231.5K |
| Jul 31, 2026 | Crocker Mary Jayne Director | Tax withheld | 14,575 | $298.5K |
| Jul 31, 2026 | Crocker Mary Jayne Director | Option exercise | 39,958 | $298.5K |
| Jul 30, 2026 | Stejskal Jessica Anne Chief Experience Officer | Option exercise | 1,600 | $12.0K |
| Jul 30, 2026 | Crocker Mary Jayne Director | Option exercise | 31 | $232 |
| Jul 30, 2026 | Crocker Mary Jayne Director | Sale | 11 | $233 |
| Jul 29, 2026 | Baack Jerry J. CEO | Sale | 11,334 | $237.0K |
| Jul 27, 2026 | Baack Jerry J. CEO | Sale | 15,900 | $330.8K |
| Jun 30, 2026 | Lawal Mohammed Director | Award | 959 | $0 |
| Jun 30, 2026 | Crocker Mary Jayne Director | Award | 479 | $0 |
| Jun 30, 2026 | Brezonik Lisa Director | Award | 959 | $0 |
| Jun 30, 2026 | Parish Douglas J. Director | Award | 479 | $0 |
| Jun 30, 2026 | Johnson James S. Director | Award | 959 | $0 |
| Jun 30, 2026 | Volk David J. Director | Award | 959 | $0 |
| Jun 30, 2026 | Urness Todd B. Director | Award | 959 | $0 |
| Jun 30, 2026 | Trutna Thomas P. Director | Award | 479 | $0 |
| Jun 30, 2026 | Juran David B. Director | Award | 959 | $0 |
| Jun 10, 2026 | Salazar Lisa M CHIEF OPERATING OFFICER | Option exercise | 1,931 | $25.0K |
| Jun 8, 2026 | Place Nicholas L. CHIEF BANKING OFFICER | Option exercise | 12,500 | $93.4K |
| Jun 5, 2026 | Place Nicholas L. CHIEF BANKING OFFICER | Sale | 4,688 | $90.4K |
| Jun 5, 2026 | Chybowski Joseph M. PRESIDENT & CFO | Sale | 7,000 | $132.7K |
| Jun 5, 2026 | Chybowski Joseph M. PRESIDENT & CFO | Option exercise | 7,000 | $52.3K |
| May 21, 2026 | Shellberg Jeffrey D. Director | Sale | 20,000 | $371.1K |
| May 21, 2026 | Crocker Mary Jayne Director | Sale | 6,525 | $120.7K |
| May 11, 2026 | Crocker Mary Jayne Director | Purchase | 205 | $4.1K |
| May 8, 2026 | Salazar Lisa M CHIEF OPERATING OFFICER | Sale | 4,162 | $77.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Bridgewater Bancshares Inc and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading